Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
A collective of investment entities tied to Partners Group has executed a significant sale of common stock in Life Time Group Holdings, Inc. (NASDAQ:LTH). The transactions, totaling approximately $23.5 million, were carried out on May 7, 2026, through several affiliated funds. This movement follows a period of notable price appreciation for LTH sha…
Entities connected to the private equity firm Leonard Green & Partners, L.P. have executed a series of large-scale stock sales involving Life Time Group Holdings, Inc. (NYSE: LTH). On May 7, 2026, these transactions resulted in a total disposal value of approximately $157,040,423. The divestment comes during a period of recent stock price strength …
John G. Danhakl, a director at Life Time Group Holdings, Inc. (NASDAQ: LTH), has completed a significant sale of common stock totaling approximately $157,040,423. The transaction, which occurred on May 7, 2026, involved the disposal of 4,991,749 shares at an average price of $31.46 per share. This divestment takes place as the company's stock conti…
A significant insider transaction has been recorded at Life Time Group Holdings, Inc. (NYSE: LTH), as director John Kristofer Galashan disposed of a substantial portion of his holdings. On May 7, 2026, the sale involved 4,991,749 shares of common stock, representing a total transaction value of approximately $157,040,423. The shares were liquidated…
Pulse Biosciences, Inc. (NASDAQ: PLSE) has seen notable insider activity following its recent quarterly financial reporting. Paul A. LaViolette, who serves as both the Chief Executive Officer and a director for the company, executed a significant acquisition of common stock on May 11, 2026. This transaction involved the purchase of 15,000 shares at…
Gajendra Sanjay, who serves as the President and Chief Operating Officer of Astera Labs, Inc. (NASDAQ: ALAB), has completed a significant sale of company common stock totaling approximately $45,716,730. The transaction took place on May 7, 2026, involving a total of 240,619 shares. These sales were conducted through automated processes established …
Affiliates linked to Access Industries have executed significant sales of common stock in DigitalOcean Holdings, Inc. (NASDAQ: DOCN), totaling approximately $60.8 million. The transactions, primarily involving AI Droplet Holdings LLC, took place on May 7 and May 11, 2026. This movement comes amidst a period of substantial growth for the cloud infra…
Chiron Real Estate Inc. (NASDAQ:XRN) saw insider activity on May 11, 2026, when Director Cole Henry purchased approximately $19,997 worth of company common stock. This transaction occurs alongside significant corporate developments, including a major entry into the senior housing sector and new financing arrangements, even as analysts adjust their …
Chiron Real Estate Inc. (NASDAQ:XRN) saw recent insider activity as director Paula Crowley acquired common stock in a transaction reported on May 11, 2026. The purchase, valued at approximately $34,000, occurred while the stock was trading near $33.54. This acquisition of 1,000 shares at a price of $34.00 per share brings Ms. Crowley's indirect own…
Michael Sentonas, the President of cybersecurity provider CrowdStrike Holdings Inc. (NASDAQ:CRWD), has completed a series of stock transactions totaling approximately $23.9 million. The sales, which involved 45,000 shares of Class A common stock, took place across two dates in May 2026. These disposals occurred while the company's stock was trading…
Jeffrey M. Stibel, the Chief Executive Officer of LegalZoom.com, Inc. (LZ), has significantly increased his direct stake in the company through a recent common stock acquisition. On May 11, 2026, Mr. Stibel purchased 125,000 shares in a transaction valued at approximately $768,987. This move comes amid a period of varied financial performance for t…
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed a sale of company stock totaling $990,448. The transaction involved 2,002 shares of Class A common stock and took place on May 8, 2026. These sales were conducted under a pre-arranged 10b5-1 trading plan that had been established earli…
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) director Sameer K. Gandhi has completed a sale of Class A common stock totaling approximately $9.23 million. The transaction, which occurred on May 8, 2026, was carried out through a 10b5-1 trading plan that had been established on June 27, 2025. This move comes at a time when the cybersecurity firm is navig…
Andrew Pardo Wright, serving as a Director at Slide Insurance Holdings, Inc. (SLDE), has completed a sale of common stock valued at approximately $119,372. The transaction occurred on May 7, 2026, involving the disposal of 6,316 shares at a price point of $18.90 per share. These assets were held indirectly via MAOV Slide, LLC, an entity where Mr. W…
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed the sale of 2,999 shares of Class A common stock. The total value realized from these transactions reached $1,546,245. Executed on May 7 and May 8, 2026, the sales occurred within a price range between $487.26 and $508.41 per share.The…
Lucas Shannon, serving as the President and Chief Operating Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed two separate transactions involving the sale of common stock. These sales, which occurred in early May 2026, resulted in a total liquidation of approximately $491,262 worth of shares. The transactions were conducted un…
Bruce Lucas, the Chief Executive Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed a series of stock sales totaling approximately $4.97 million. These transactions, which were executed via an indirect entity, took place in early May 2026. The divestments were part of a pre-arranged 10b5-1 trading plan that had been established…
Bryan Giraudo, a director at Protagonist Therapeutics, Inc. (NASDAQ: PTGX), has completed a series of stock transactions totaling approximately $5.92 million. These movements, which included both the exercise of stock options and the subsequent sale of common stock, took place on May 7 and May 8, 2026, according to recent SEC filings. While the com…
Expensify, Inc. (NASDAQ:EXFY) Chief Executive Officer David Michael Barrett has completed a sale of company stock totaling $32,400. The transaction, which involved 30,000 shares of Class A Common Stock, took place on May 1, 2026. This move by the top executive occurs against a backdrop of significant recent volatility for EXFY, as the company grapp…
Dylan C. Smith, the Chief Financial Officer of Box, Inc. (NASDAQ: BOX), has completed the sale of Class A Common Stock totaling $592,093. The transactions, which occurred on May 11, 2026, were executed in accordance with a Rule 10b5-1 trading plan that Smith had previously established on May 29, 2025. These scheduled sales took place as the company…
Jitendra Mohan, the Chief Executive Officer and a director of Astera Labs, Inc. (NASDAQ:ALAB), has completed a sale of common stock totaling approximately $28.01 million. The transaction, which took place on May 7, 2026, involved the disposal of 140,951 shares. This divestment was conducted through an automated process under a Rule 10b5-1 trading p…
Olivia Nottebohm, the Chief Operating Officer of Box Inc. (NASDAQ: BOX), has completed a sale of company stock totaling $313,882. The transaction involved 12,470 shares of Class A Common Stock and was conducted on May 8, 2026. This divestment was carried out under a Rule 10b5-1 trading plan that Nottebohm had established previously on July 9, 2025.…
James V. Caruso, the Chief Executive Officer of Cellectar Biosciences, Inc. (NASDAQ: CLRB), has executed a series of transactions to increase his direct ownership in the company. On May 7, 2026, Mr. Caruso purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This acquisition brings his to…
Jarrod Longcor, the Chief Operating Officer of Cellectar Biosciences, Inc. (NASDAQ:CLRB), has executed a series of transactions involving both common stock and warrants. On May 7, 2026, Longcor purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This activity comes as the company navigat…
Sarbani Chaudhuri, serving as the Chief Commercial and Medical Affairs Officer for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), recently completed a transaction involving the sale of company common stock. On May 7, 2026, Ms. Chaudhuri sold 17,650 shares of Rocket Pharmaceuticals common stock at a price per share of $3.838. This transaction resulted…
